跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VOLTADOL FORTE 23,2 MG/G GEL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VOLTADOL FORTE 23,2 MG/G GEL
Approved
STANDARD
VOLTADOL FORTE 23,2 MG/G GEL
Glaxosmithkline Consumer Healthcare S.R.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 14, 2023
Approval ID
a213f8a580e8b962
Company
Glaxosmithkline Consumer Healthcare S.R.L.
Type
Standard
Approval Details
Approval Id
a213f8a580e8b962
Drug Cima Aemps Name
VOLTADOL FORTE 23,2 MG/G GEL
Register Number
13380-2020-01-24IP
Holder Company Name
Glaxosmithkline Consumer Healthcare S.R.L.
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2023-12-14
Dosage Form
GEL
Dose
23,2 mg/g
Route Of Administration
USO CUTÁNEO
Prescription Type
Sin Receta
Commercialized
No
Company Name
Glaxosmithkline Consumer Healthcare S.R.L.
Active Ingredients
DICLOFENACO DIETILAMINA
23.2 mg/g
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 14, 2023
Approval ID
a213f8a580e8b962
Type
Standard
Back to CIMA-AEMPS Approvals